molecules-logo

Journal Browser

Journal Browser

Medical Nanocapsules

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 13479

Special Issue Editor


E-Mail Website
Guest Editor
Faculty of Chemistry, CeNIDE, University Duisburg-Essen, Universitaetsstr. 5, 45141 Essen, Germany
Interests: nanocapsules; vesicles; biopolymers; NMR spectroscopy; origin of life

Special Issue Information

Dear Colleagues,

As quite universal carrier systems, nanocapsules have played a central role in many prominent developments of human medicine. With sizes between 10 and 1000 nm, they go a little bit beyond what are usually counted as nanostructures. However, their key structural element, the solid spherical shell around a fluid core, is a true nanoscopic device, with particular properties that determine the functionality of the whole carrier system. With this in mind, nanocapsules are true achievements of nanotechnology in medical sciences. The main target of their development varies by a wide range: they can serve as simple containers with specific release properties for the encapsulated active components, but they can also be equipped to cross physiological barriers or bind towards specific tissues and serve as drug targeting devices. However, there is much more to it: capsule membranes may be functionalized so that they open on external influences or signals, they may play an active part in a molecular exchange in a physiological environment, they can replace actual body cells, they may be an integrated part of MRI diagnostics, and they may even be developed towards functional elements which allow for the capsules to potentially act as nano-robots.

An important issue for the development of nanocapsules is the choice of materials, especially for the capsule membrane. Naturally, they need to be biodegradable, or at least completely inert in a physiological environment. The membrane could be biomimetical in a sense that it reproduces a biological membrane, leading to the idea to use modified membrane vesicles as nanocapsules. Another material class predestinated for this application is biopolymers, where all varieties are possible candidates: peptides, proteins and polysaccharides or cross-linked lipids are among the most promising. On the other hand, synthetic polymers or even inorganic materials may be usable as well. The active ingredient may either be integrated during the capsule preparation or could be introduced into the finished capsule structures. The same holds for membrane functionalization, which may be an integral part of the capsule preparation or could as well be added to the finished capsules.

This planned Special Issue deals with a wide variety of aspects regarding the medical use of nanocapsules. It starts with the material choice for the capsule membranes, followed by suitable preparation procedures. It continues with loading processes, specific functionalization and targeting issues. Furthermore, of course, it includes release processes which may be connected to simple first-order decay over time, but may also be triggered externally. Finally, it deals with specific medical applications which demonstrate the general power of this approach.

Prof. Dr. Christian Mayer
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanocapsules
  • carrier system
  • controlled release
  • drug targeting

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

14 pages, 3652 KiB  
Article
An Approach to Minimize Tumour Proliferation by Reducing the Formation of Components for Cell Membrane
by Inmaculada de Dios-Pérez, Álvaro González-Garcinuño and Eva María Martín del Valle
Molecules 2022, 27(9), 2735; https://doi.org/10.3390/molecules27092735 - 24 Apr 2022
Cited by 3 | Viewed by 1781
Abstract
Isoprenoids are natural compounds essential for a great number of cellular functions. One of them is farnesol (FOH), which can reduce cell proliferation, but its low solubility in aqueous solvents limits its possible clinical use as a pharmacological tool. One alternative is the [...] Read more.
Isoprenoids are natural compounds essential for a great number of cellular functions. One of them is farnesol (FOH), which can reduce cell proliferation, but its low solubility in aqueous solvents limits its possible clinical use as a pharmacological tool. One alternative is the use of cyclodextrins (CDs) which house hydrophobic molecules forming inclusion complexes. To assess FOH potential application in anticancer treatments, Sulfobutylated β-cyclodextrin Sodium Salt (SBE-β-CD) was selected, due to it has high solubility, approbation by the FDA, and numerous studies that ensure its safety to be administered parenterally or orally without nephrotoxicity associated. The therapeutic action of farnesol and complex were studied in different carcinoma cells, compared with a normal cell line. Farnesol showed selectivity, affecting the viability of colon and liver cancer cells more than in breast cancer cells and fibroblasts. All cells suffered apoptosis after being treated with 150 μM of free FOH, but the complex reduced their cell viability between 50 and 75%. Similar results were obtained for both types of isomers, and the addition of phosphatidylcholine reverses this effect. Finally, cell cycle analysis corroborates the action of FOH as inducer of a G0/G1 phase; when the cells were treated using the complex form, this viability was reduced, reaching 50% in the case of colon and liver, 60% in fibroblasts, and only 75% in breast cancer. Full article
(This article belongs to the Special Issue Medical Nanocapsules)
Show Figures

Figure 1

17 pages, 4802 KiB  
Article
Pathways for Oral and Rectal Delivery of Gold Nanoparticles (1.7 nm) and Gold Nanoclusters into the Colon: Enteric-Coated Capsules and Suppositories
by Shabnam Hosseini, Oliver Wetzel, Kathrin Kostka, Marc Heggen, Kateryna Loza and Matthias Epple
Molecules 2021, 26(16), 5069; https://doi.org/10.3390/molecules26165069 - 21 Aug 2021
Cited by 8 | Viewed by 2863
Abstract
Two ways to deliver ultrasmall gold nanoparticles and gold-bovine serum albumin (BSA) nanoclusters to the colon were developed. First, oral administration is possible by incorporation into gelatin capsules that were coated with an enteric polymer. These permit the transfer across the stomach whose [...] Read more.
Two ways to deliver ultrasmall gold nanoparticles and gold-bovine serum albumin (BSA) nanoclusters to the colon were developed. First, oral administration is possible by incorporation into gelatin capsules that were coated with an enteric polymer. These permit the transfer across the stomach whose acidic environment damages many drugs. The enteric coating dissolves due to the neutral pH of the colon and releases the capsule’s cargo. Second, rectal administration is possible by incorporation into hard-fat suppositories that melt in the colon and then release the nanocarriers. The feasibility of the two concepts was demonstrated by in-vitro release studies and cell culture studies that showed the easy redispersibility after dissolution of the respective transport system. This clears a pathway for therapeutic applications of drug-loaded nanoparticles to address colon diseases, such as chronic inflammation and cancer. Full article
(This article belongs to the Special Issue Medical Nanocapsules)
Show Figures

Figure 1

Review

Jump to: Research

16 pages, 763 KiB  
Review
A Mini-Review on Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Topical Delivery of Phytochemicals for the Treatment of Acne Vulgaris
by Romchat Chutoprapat, Peerawas Kopongpanich and Lai Wah Chan
Molecules 2022, 27(11), 3460; https://doi.org/10.3390/molecules27113460 - 27 May 2022
Cited by 29 | Viewed by 5572
Abstract
Acne vulgaris (acne) is one of the most common dermatological problems affecting adolescents and young adults. Although acne may not lead to serious medical complications, its psychosocial effects are tremendous and scientifically proven. The first-line treatment for acne is topical medications composed of [...] Read more.
Acne vulgaris (acne) is one of the most common dermatological problems affecting adolescents and young adults. Although acne may not lead to serious medical complications, its psychosocial effects are tremendous and scientifically proven. The first-line treatment for acne is topical medications composed of synthetic compounds, which usually cause skin irritation, dryness and itch. Therefore, naturally occurring constituents from plants (phytochemicals), which are generally regarded as safe, have received much attention as an alternative source of treatment. However, the degradation of phytochemicals under high temperature, light and oxygen, and their poor penetration across the skin barrier limit their application in dermatology. Encapsulation in lipid nanoparticles is one of the strategies commonly used to deliver drugs and phytochemicals because it allows appropriate concentrations of these substances to be delivered to the site of action with minimal side effects. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) are promising delivery systems developed from the combination of lipid and emulsifier. They have numerous advantages that include biocompatibility and biodegradability of lipid materials, enhancement of drug solubility and stability, ease of modulation of drug release, ease of scale-up, feasibility of incorporation of both hydrophilic and lipophilic drugs and occlusive moisturization, which make them very attractive carriers for delivery of bioactive compounds for treating skin ailments such as acne. In this review, the concepts of SLNs and NLCs, methods of preparation, characterization, and their application in the encapsulation of anti-acne phytochemicals will be discussed. Full article
(This article belongs to the Special Issue Medical Nanocapsules)
Show Figures

Graphical abstract

9 pages, 1032 KiB  
Review
Micro- and Nanocapsules Based on Artificial Peptides
by Huayang Feng
Molecules 2022, 27(4), 1373; https://doi.org/10.3390/molecules27041373 - 17 Feb 2022
Cited by 3 | Viewed by 2638
Abstract
The encapsulation of active ingredients into solid capsules from biodegradable materials has received significant attention over the last decades. In this short review, we focus on the formation of micro- and nano-sized capsules and emulsions based on artificial peptides as a fully degradable [...] Read more.
The encapsulation of active ingredients into solid capsules from biodegradable materials has received significant attention over the last decades. In this short review, we focus on the formation of micro- and nano-sized capsules and emulsions based on artificial peptides as a fully degradable material. It deals with various approaches for the preparation of peptide-based capsules as well as with their crucial properties such as size and stability. We categorize all preparation procedures into three basic approaches: self-assembly, polymerization and crosslinking, and layer-by-layer technology. This article is meant to offer a short overview over all successful methods suitable for obtaining access to these very promising carrier systems. Full article
(This article belongs to the Special Issue Medical Nanocapsules)
Show Figures

Figure 1

Back to TopTop